These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 12747905

  • 1. Combined salmeterol and fluticasone for COPD.
    Khamis RY, Rajakulasingam RK.
    Lancet; 2003 May 10; 361(9369):1652; author reply 1652-3. PubMed ID: 12747905
    [No Abstract] [Full Text] [Related]

  • 2. Combined salmeterol and fluticasone for COPD.
    Vassiliou V.
    Lancet; 2003 May 10; 361(9369):1651; author reply 1652-3. PubMed ID: 12747901
    [No Abstract] [Full Text] [Related]

  • 3. COPD: don't use fluticasone + salmeterol. Patients treated with inhaled fluticasone for chronic obstructive pulmonary disease (COPD) are more prone to pneumonia.
    Prescrire Int; 2007 Dec 10; 16(92):257-8. PubMed ID: 18092426
    [No Abstract] [Full Text] [Related]

  • 4. [New studies refute steroid opponents. COPD--after all a case for corticosteroids?].
    Calverley P.
    MMW Fortschr Med; 2003 Jun 12; 145(24):20. PubMed ID: 12866294
    [No Abstract] [Full Text] [Related]

  • 5. Fluticasone/salmeterol: labeling change.
    Prescrire Int; 2008 Dec 12; 17(98):229. PubMed ID: 19418648
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevention of death in COPD.
    Barnes PJ.
    N Engl J Med; 2007 May 24; 356(21):2211; author reply 2213-4. PubMed ID: 17522406
    [No Abstract] [Full Text] [Related]

  • 12. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
    Vestbo J, Pauwels R, Anderson JA, Jones P, Calverley P, TRISTSAN study group.
    Thorax; 2005 Apr 24; 60(4):301-4. PubMed ID: 15790985
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.
    Kardos P, Wencker M, Glaab T, Vogelmeier C.
    Am J Respir Crit Care Med; 2007 Jan 15; 175(2):144-9. PubMed ID: 17053207
    [Abstract] [Full Text] [Related]

  • 15. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, TORCH investigators.
    N Engl J Med; 2007 Feb 22; 356(8):775-89. PubMed ID: 17314337
    [Abstract] [Full Text] [Related]

  • 16. Combined salmeterol and fluticasone for COPD.
    MacAllister R.
    Lancet; 2003 May 10; 361(9369):1651; author reply 1652-3. PubMed ID: 12747902
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tiotropium in combination with placebo, salmeterol, or fluticasone salmeterol for chronic obstructive pulmonary disease: possible confounding effect of treatment withdrawal?
    Brown SM.
    Ann Intern Med; 2007 Dec 18; 147(12):882; author reply 882-3. PubMed ID: 18087061
    [No Abstract] [Full Text] [Related]

  • 20. The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.
    Make B, Hanania NA, ZuWallack R, Kalberg C, Emmett A, Brown CP, Knobil K.
    Clin Ther; 2005 May 18; 27(5):531-42. PubMed ID: 15978302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.